Javascript must be enabled to continue!
GW24-e3174 A trial overexpression of ACE2 improves the canine rapid atrial pacing-induced structural remodelling
View through CrossRef
Objectives
Atrial fibrillation (AF) is associated with significant morbidity and mortality. Substantial evidence suggests that the renin angiotensin system (RAS) has a role in the pathogenesis of AF. Angiotensin-converting enzyme 2 (ACE2), a monocarboxypeptidase capable of metabolising angiotensin II (Ang II) into angiotensin-(1-7) [Ang-(1-7)], has emerged as a potential therapeutic target. The purpose of this study was to investigate whether atrial overexpression of ACE2 by homogeneous transmural atrial gene transfer can reverse AF induced atrial remodelling and their mechanisms in a canine atrial pacing model.
Methods
Twenty-eight mongrel dogs were randomly divided into 4 groups: Sham-operated, control, gene therapy with Ad-EGFP (adenovirus-enhanced green fluorescent protein) and gene therapy with Ad-ACE2 (Ad-ACE2 group) (n = 7 per subgroup). Sustained AF was induced in all dogs besides Sham-operated group by atrial rapid pacing at 450 beats/min for 2 weeks. All dogs underwent an invasive electrophysiology study, then receveid epicardial gene painting. Three weeks after gene transfer, all animals underwent repeat electrophysiology study, histology, and molecular studies.
Results
The Ad-ACE2 group showed increased ACE2, Angiotensin-(1-7) and AT2R expression, and decreased Angiotensin II and AT1R expression in comparison with Ad-EGFP and control groups. ACE2 overexpression attenuated atrial tachypacing induced increase in the levels of activated extracellular signal-regulated kinases (ERK1/2) and mitogen-activated protein kinases (p38MAPK), and decrease in the levels of MAPK phosphatase 1, resulting in attenuation of atrial fibrosis marker, collagen protein and transforming growth factor-β1. Additionally, ACE2 overexpression also ameliorated tachypacing-induced up regulation of connexin 40 and down regulation of connexin 43, Cav1.2 and Kv4.2, and significantly decreased the inducibility and duration of AF.
Conclusions
ACE2 overexpression could shift the RAS balance towards the protective axis, attenuate cardiac fibrosis remodelling associated with up-regulation of MKP-1 to reduce MAPK activities, ameliorate tachypacing-induced ion channel and connexin remodelling, and subsequently reduce the inducibility and duration of AF. Therefore, overexpression of ACE2 by homogeneous transmural atrial gene transfer could improve atria electrical and structural remodelling in a canine atrial pacing model.
Title: GW24-e3174 A trial overexpression of ACE2 improves the canine rapid atrial pacing-induced structural remodelling
Description:
Objectives
Atrial fibrillation (AF) is associated with significant morbidity and mortality.
Substantial evidence suggests that the renin angiotensin system (RAS) has a role in the pathogenesis of AF.
Angiotensin-converting enzyme 2 (ACE2), a monocarboxypeptidase capable of metabolising angiotensin II (Ang II) into angiotensin-(1-7) [Ang-(1-7)], has emerged as a potential therapeutic target.
The purpose of this study was to investigate whether atrial overexpression of ACE2 by homogeneous transmural atrial gene transfer can reverse AF induced atrial remodelling and their mechanisms in a canine atrial pacing model.
Methods
Twenty-eight mongrel dogs were randomly divided into 4 groups: Sham-operated, control, gene therapy with Ad-EGFP (adenovirus-enhanced green fluorescent protein) and gene therapy with Ad-ACE2 (Ad-ACE2 group) (n = 7 per subgroup).
Sustained AF was induced in all dogs besides Sham-operated group by atrial rapid pacing at 450 beats/min for 2 weeks.
All dogs underwent an invasive electrophysiology study, then receveid epicardial gene painting.
Three weeks after gene transfer, all animals underwent repeat electrophysiology study, histology, and molecular studies.
Results
The Ad-ACE2 group showed increased ACE2, Angiotensin-(1-7) and AT2R expression, and decreased Angiotensin II and AT1R expression in comparison with Ad-EGFP and control groups.
ACE2 overexpression attenuated atrial tachypacing induced increase in the levels of activated extracellular signal-regulated kinases (ERK1/2) and mitogen-activated protein kinases (p38MAPK), and decrease in the levels of MAPK phosphatase 1, resulting in attenuation of atrial fibrosis marker, collagen protein and transforming growth factor-β1.
Additionally, ACE2 overexpression also ameliorated tachypacing-induced up regulation of connexin 40 and down regulation of connexin 43, Cav1.
2 and Kv4.
2, and significantly decreased the inducibility and duration of AF.
Conclusions
ACE2 overexpression could shift the RAS balance towards the protective axis, attenuate cardiac fibrosis remodelling associated with up-regulation of MKP-1 to reduce MAPK activities, ameliorate tachypacing-induced ion channel and connexin remodelling, and subsequently reduce the inducibility and duration of AF.
Therefore, overexpression of ACE2 by homogeneous transmural atrial gene transfer could improve atria electrical and structural remodelling in a canine atrial pacing model.
Related Results
GW24-e1111 The effects of ACE2 on RAS system by painting on epicadial in atrial rapid pacing canine
GW24-e1111 The effects of ACE2 on RAS system by painting on epicadial in atrial rapid pacing canine
Objectives
To study the effects of ACE2 on RAS system in rapid atrial pacing canine, and to investigate the possible mechanisms of ACE2 in improving atrial fibril...
e0650 The effects of biventricular synchronous pacing on CBF, MVO2 and CWE in dogs
e0650 The effects of biventricular synchronous pacing on CBF, MVO2 and CWE in dogs
Objective
To compare the effects of biventricular synchronous pacing with different pacing site on coronary Blood flow (CBF), myocardial oxygen consumption (MVO2)...
THE TIME-DEPENDENT STUDY ON CONNECTIVE TISSUE GROWTH FACTOR AND NERVE REMODELLING IN ATRIAL FIBRILLATION
THE TIME-DEPENDENT STUDY ON CONNECTIVE TISSUE GROWTH FACTOR AND NERVE REMODELLING IN ATRIAL FIBRILLATION
Objectives
To dynamically observe the mechanism of connective tissue growth factor and nerve remodelling in the atrial fibrillation rabbit models.
...
Perindopril Reduce SARS-COV-2 Spike-ACE2 Binding, ACE2 Overexpression and Cytokine Storm in Adipocyte Cell Infected with SARS-COV-2
Perindopril Reduce SARS-COV-2 Spike-ACE2 Binding, ACE2 Overexpression and Cytokine Storm in Adipocyte Cell Infected with SARS-COV-2
Abstract
Funding Acknowledgements
Type of funding sources: Public Institution(s). Main funding source(s): Ristekdikti
...
Comprehensive Bioinformatics analysis of angiotensin-converting enzyme 2 (ACE2)
Comprehensive Bioinformatics analysis of angiotensin-converting enzyme 2 (ACE2)
Abstract
ACE2, a member of the angiotensin converting enzyme family, plays an irreplaceable role in the renin-angiotensin system. And the variations of ACE2 are regarded as...
Loss of ACE2 augments angiotensin II-induced myocardial hypertrophy and remodeling with increased Profilin-1 expression
Loss of ACE2 augments angiotensin II-induced myocardial hypertrophy and remodeling with increased Profilin-1 expression
Introduction
Angiotensin (Ang) II, the main effector of the renin-angiotensin system (RAS), has recently shown to enhance the expression of Profilin-1, which func...
Abstract P431: SARS-CoV-2-induced Inflammation In Human Endothelial Cells Involves ACE2
Abstract P431: SARS-CoV-2-induced Inflammation In Human Endothelial Cells Involves ACE2
COVID-19 is associated with hypertension, where endotheliitis and endothelial dysfunction are risk factors. Considering the relationship between the viral spike protein and ACE2, i...
Viral stimulation modulates endotype-related ACE2 expression in eosinophilic chronic rhinosinusitis
Viral stimulation modulates endotype-related ACE2 expression in eosinophilic chronic rhinosinusitis
Background: Angiotensin-converting enzyme 2 (ACE2), a receptor targeted by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is highly expressed in the nasal mucosa...

